The Utility of BDNF Detection in Assessing Severity of Huntington’s Disease

Brain-derived neurotrophic factor (BDNF) is involved in the survival and maturation of neurons, and also promotes and controls neurogenesis. Its levels are lowered in many neurodegenerative diseases, including Huntington’s disease (HD). Clinical pictures of HD can be very diverse, which makes it difficult to assess its severity; however, molecular markers may be helpful. The aim of the study was to determine the relationship between HD severity and the plasma BDNF concentration in HD patients. The study recruited 42 patients with diagnosed and genetically confirmed HD and 40 healthy volunteers. BDNF levels were determined in plasma with the enzyme-linked immunosorbent assay (ELISA). Correlations between BDNF levels and clinical profiles and HD severity were also investigated. The BDNF level was significantly lower in HD patients compared to the control. There was no correlation between the BDNF level and motor symptoms and cognitive impairment. In the early disease stages, BDNF levels were associated with a better neurological examination, independence, and functional evaluation, in contrast to later HD stages, where the correlations were inverse. Multidirectional correlations between parameters of saccadic disorders and the BDNF level do not allow for drawing a conclusion, whether or not there is a relationship between the severity of saccadic disorders and the BDNF concentration.

[1]  M. Wójcik-Pędziwiatr,et al.  Is TGF-β1 a Biomarker of Huntington’s Disease Progression? , 2021, Journal of clinical medicine.

[2]  M. Lasaga,et al.  Astrocytes from cortex and striatum show differential responses to mitochondrial toxin and BDNF: implications for protection of striatal neurons expressing mutant huntingtin , 2020, Journal of neuroinflammation.

[3]  J. Corey-Bloom,et al.  Evaluation of Biochemical and Epigenetic Measures of Peripheral Brain-Derived Neurotrophic Factor (BDNF) as a Biomarker in Huntington’s Disease Patients , 2020, Frontiers in Molecular Neuroscience.

[4]  P. Bekinschtein,et al.  Brain-Derived Neurotrophic Factor: A Key Molecule for Memory in the Healthy and the Pathological Brain , 2019, Front. Cell. Neurosci..

[5]  B. Lutz,et al.  ESC-Derived BDNF-Overexpressing Neural Progenitors Differentially Promote Recovery in Huntington's Disease Models by Enhanced Striatal Differentiation , 2016, Stem cell reports.

[6]  Undurti N. Das,et al.  Brain-derived neurotrophic factor and its clinical implications , 2015, Archives of medical science : AMS.

[7]  M. de Tommaso,et al.  Dysphagia in Huntington's Disease: Correlation with Clinical Features , 2015, European Neurology.

[8]  M. Mihanović,et al.  Brain-derived neurotrophic factor as a suicide factor in mental disorders , 2013, Acta Neuropsychiatrica.

[9]  N. Jetté,et al.  The incidence and prevalence of Huntington's disease: A systematic review and meta‐analysis , 2012, Movement disorders : official journal of the Movement Disorder Society.

[10]  Jagan A. Pillai,et al.  Clinical severity of Huntington's disease does not always correlate with neuropathologic stage , 2012, Movement disorders : official journal of the Movement Disorder Society.

[11]  Eduardo D. Martín,et al.  Conditional BDNF release under pathological conditions improves Huntington's disease pathology by delaying neuronal dysfunction , 2011, Molecular Neurodegeneration.

[12]  Edward J. Wild,et al.  Brain-Derived Neurotrophic Factor in Patients with Huntington's Disease , 2011, PloS one.

[13]  M. Hayden,et al.  BDNF Overexpression in the Forebrain Rescues Huntington's Disease Phenotypes in YAC128 Mice , 2010, The Journal of Neuroscience.

[14]  E. Cattaneo,et al.  Brain-derived neurotrophic factor in neurodegenerative diseases , 2009, Nature Reviews Neurology.

[15]  R. Roos,et al.  Behavioural problems in Huntington's disease using the Problem Behaviours Assessment. , 2008, General hospital psychiatry.

[16]  M. MacDonald,et al.  RESEARCH ARTICLE: Systematic Assessment of BDNF and Its Receptor Levels in Human Cortices Affected by Huntington's Disease , 2007, Brain pathology.

[17]  S. Calza,et al.  Low brain‐derived neurotrophic factor (BDNF) levels in serum of Huntington's disease patients , 2007, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[18]  E. Cattaneo,et al.  Role of brain-derived neurotrophic factor in Huntington's disease , 2007, Progress in Neurobiology.

[19]  G. Mengod,et al.  Brain-Derived Neurotrophic Factor Regulates the Onset and Severity of Motor Dysfunction Associated with Enkephalinergic Neuronal Degeneration in Huntington's Disease , 2004, The Journal of Neuroscience.

[20]  Fabrice P Cordelières,et al.  Huntingtin Controls Neurotrophic Support and Survival of Neurons by Enhancing BDNF Vesicular Transport along Microtubules , 2004, Cell.

[21]  M. Egan,et al.  The BDNF val66met Polymorphism Affects Activity-Dependent Secretion of BDNF and Human Memory and Hippocampal Function , 2003, Cell.

[22]  Ruoyan Chen,et al.  Brain-derived Neurotrophic Factor Is Stored in Human Platelets and Released by Agonist Stimulation , 2002, Thrombosis and Haemostasis.

[23]  Blair R. Leavitt,et al.  Loss of Huntingtin-Mediated BDNF Gene Transcription in Huntington's Disease , 2001, Science.

[24]  I. Ferrer,et al.  Brain-derived neurotrophic factor in Huntington disease , 2000, Brain Research.

[25]  R. Paus,et al.  Abundant production of brain-derived neurotrophic factor by adult visceral epithelia. Implications for paracrine and target-derived Neurotrophic functions. , 1999, The American journal of pathology.

[26]  William A Banks,et al.  Transport of brain-derived neurotrophic factor across the blood–brain barrier , 1998, Neuropharmacology.

[27]  Jane S. Paulsen,et al.  Unified Huntington's disease rating scale: Reliability and consistency , 1996, Movement disorders : official journal of the Movement Disorder Society.

[28]  M. Escobar,et al.  Neurotrophins and synaptic plasticity. , 2013, Current topics in behavioral neurosciences.